ISSN 1308-7649 | E-ISSN 2148-3817
RELATED ARTICLES
Original Article
Determination of Anxiety, Health Anxiety and Somatosensory Amplification Levels in Individuals with Benign Paroxysmal Positional Vertigo
(J Int Adv Otol ; : -)
DOI: 10.5152/iao.2019.6874
Intratympanic Steroid Treatment of Bell’s Palsy in Patients with Comorbid Disease: A Preliminary Report
(J Int Adv Otol ; : -)
DOI: 10.5152/iao.2019.5415
A Comparison of Two Vasoactive/Vasodilative Agents in Combination with Corticosteroid for Treatment of Sudden Sensorineural Hearing Loss
(J Int Adv Otol 2014; 10: 240-245)
DOI: 10.5152/iao.2014.102
Co-existence of Benign Paroxysmal Positional Vertigo and Meniere’s Syndrome
(J Int Adv Otol 2017; 13: 65-68)
DOI: 10.5152/iao.2016.2906
Efficacy of Cortexin and Methylprednisolone on Traumatic Facial Nerve Paralysis
(J Int Adv Otol 2016; 12: 303-309)
DOI: 10.5152/iao.2016.1166
Evaluation of Cervical Vestibular-Evoked Myogenic Potential Findings in Benign Paroxysmal Positional Vertigo
(J Int Adv Otol 2016; 12: 316-320)
DOI: 10.5152/iao.2016.2170
The Role of Oxidative Stress and Inflammatory Mediators in Benign Paroxysmal Positional Vertigo
(J Int Adv Otol 2016; 12: 101-105)
DOI: 10.5152/iao.2015.1412
Caloric Analysis of Patients with Benign Paroxysmal Positional Vertigo
(J Int Adv Otol 2017; 13: 390-393)
DOI: 10.5152/iao.2017.3312
Intratympanic Methylprednisolone versus Dexamethasone for the Primary Treatment of Idiopathic Sudden Sensorineural Hearing Loss
(J Int Adv Otol 2018; 14: 451-455)
DOI: 10.5152/iao.2018.4871
Probable Benign Paroxysmal Positional Vertigo Converts into Definite BPPV in One in Six Patients
(J Int Adv Otol 2018; 14: 456-458)
DOI: 10.5152/iao.2018.4862
A Pilot Study Using Intratympanic Methylprednisolone for Treatment of Persistent Posterior Canal Benign Paroxysmal Positional Vertigo
(J Int Adv Otol 2016; 12: 321-325)
DOI: 10.5152/iao.2016.3014
Determination of Anxiety, Health Anxiety and Somatosensory Amplification Levels in Individuals with Benign Paroxysmal Positional Vertigo
(J Int Adv Otol ; : -)
DOI: 10.5152/iao.2019.6874
Evaluation of Benign Paroxysmal Positional Vertigo in American Football Players
(J Int Adv Otol 2018; 14: 295-298)
DOI: 10.5152/iao.2018.4384
Oxidative Status in Patients with Benign Paroxysmal Positional Vertigo
(J Int Adv Otol 2018; 14: 299-303)
DOI: 10.5152/iao.2018.4756
Two-Hour Follow-Up is Equivalent to One-Day Follow-Up of Posterior Canal Benign Paroxysmal Positional Vertigo
(J Int Adv Otol 2019; 15: 141-145)
DOI: 10.5152/iao.2018.5328
Intratympanic Methylprednisolone versus Dexamethasone for the Primary Treatment of Idiopathic Sudden Sensorineural Hearing Loss
(J Int Adv Otol ; : -)
DOI: 10.5152/iao.2018.4871
Intratympanic Methylprednisolone versus Dexamethasone for the Primary Treatment of Idiopathic Sudden Sensorineural Hearing Loss
(J Int Adv Otol ; : -)
DOI: 10.5152/iao.2018.4871
Key Words
Authors
All
Author's Corner
Reviewer's Corner
Survey
AVES | Copyright © 2019 The European Academy of Otology and Neurotology | Latest Update: 15.08.2019